Malignant Lymphomas
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas (NCT01800630) | InnoPharmax Inc. | 2013-04-01 |
| Biosimilar Retacritâ„¢ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology (NCT01626547) | Hospira, now a wholly owned subsidiary of Pfizer | 2010-12-01 |
| Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor (NCT01212341) | Seoul National University Hospital | 2010-09-01 |
| Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies (NCT01065025) | 4SC AG | 2010-01-01 |
Track Malignant Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.